Clinical Trial

Study of SG301 for Renal AMR After Transplantation

Name: Study of SG301 for Renal AMR After Transplantation — clinical trial record (NCT07764627)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the safety and tolerability of SG301 injection in patients with antibody-mediated rejection (AMR) after renal transplantation.

Trial Details

NCT Number	NCT07764627
Lead Sponsor	Hangzhou Sumgen Biotech Co., Ltd.
Conditions	Antibody Mediated Rejection
Enrollment	10 participants
Start Date	2026-09-01
Primary Completion	2027-03-31 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-14